A randomised controlled trial of the effect of exercise training on exercise capacity in older patients with heart failure

ISRCTN ISRCTN51615566
DOI https://doi.org/10.1186/ISRCTN51615566
Secondary identifying numbers METM HF/ex
Submission date
29/05/2007
Registration date
03/07/2007
Last edited
21/05/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Exercise training seems to offer benefits to younger people with heart failure, but many exercise programmes are not suitable for older people to take part in. An exercise programme has been developed specifically for older people with heart failure, and the aim of this study is to test whether the exercise programme improves physical function, symptoms and quality of life in older people with heart failure.

Who can participate?
Patients aged 70 or older with chronic heart failure

What does the study involve?
Participants are randomly allocated to one of two groups: either to an exercise training group or to a group who receives usual care i.e. no exercise. Participants come to the research clinic on three occasions: at the start of the study, again after 8 weeks, and after 24 weeks. At each visit, participants complete questionnaires about their symptoms, quality of life, how active they are, and about their mood. They undergo walking and leg strength tests and are asked to wear a small box clipped to their belt during the day for seven days to record how much walking and other activity they do. Participants in the usual care group receive the same care and treatment as they have at the moment. Participants in the exercise training group come twice a week for 8 weeks to small group exercise sessions at the hospital. Taxi transport is provided to bring them back and forward for each session. Each session is led by an experienced physiotherapist, who takes care that each person exercises to their own individual ability. The sessions last up to 1 hour. Most of the exercises are done sitting in a chair, and some involve using elastic bands to help the arm and leg muscles to work harder. The therapist also guides brief talks about exercise, its benefits, how to get started and how to deal with setbacks. A leaflet with this information is provided. After 8 weeks, participants have learned the exercises and continue with the exercises at home for 16 weeks more. During this time, the physiotherapist stays in touch by phone to encourage participants and to help them overcome any problems. Participants also record their exercises and activities in a diary.

What are the possible benefits and risks of participating?
The exercise programme may improve participants’ symptoms, give them more energy, and allow them to do more. This is not guaranteed, which is this study is needed. The programme of exercise training has been shown to be safe, and the exercise is supervised by an experienced therapist for the first 8 weeks. Sudden, vigorous exercise can be hazardous for people of any age, but it is not part of this study. Participants may feel a bit more tired than usual immediately after the exercise session, or even the next day.

Where is the study run from?
University of Dundee (UK)

When is the study starting and how long is it expected to run for?
August 2007 to August 2010

Who is funding the study?
Chief Scientist Office (UK)

Who is the main contact?
Prof. Marion McMurdo
m.e.t.mcmurdo@dundee.ac.uk

Contact information

Prof Marion McMurdo
Scientific

Section of Ageing and Health
Division of Medicine and Therapeutics
University of Dundee
Ninewells Hospital and Medical School
Dundee
DD1 9SY
United Kingdom

Phone +44 (0)1382 632436
Email m.e.t.mcmurdo@dundee.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleA randomised controlled trial of the effect of exercise training on exercise capacity in older patients with heart failure
Study objectivesExercise training is known to benefit younger patients with heart failure. However most heart failure patients are older. We aim to recruit heart failure patients aged 70 years or older to either 24 weeks of exercise training or usual care. The exercise training program was developed in a pilot study. The study question: Is the newly developed exercise program effective in improving exercise capacity in older people with chronic heart failure?
Ethics approval(s)Tayside Committee on Medical Ethics A, 09/02/2007, ref: 07/S1404/1
Health condition(s) or problem(s) studiedChronic heart failure
InterventionIntervention group: Eight weeks of twice per week therapist-led supervised small group intermittent functional aerobic exercise and strength training, with the duration of sessions gradually increased to 60 minutes. This will be followed by a 16-week home-based exercise phase, which will include self-monitoring and telephone instruction and encouragement from the therapist.

The control group will receive usual care.
Intervention typeBehavioural
Primary outcome measureChange in 6 minute walking distance, recorded at baseline, 8 and 24 weeks
Secondary outcome measuresThe following will be recorded at baseline, 8 and 24 weeks:
1. Change in quadriceps muscle strength
2. Repetitive strength
3. Incremental shuttle walk test
4. Quality of life
5. Carer strain
6. Mood and self reported function
Overall study start date06/08/2007
Completion date05/08/2010

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants112
Key inclusion criteriaPatients will be recruited from day hospital, heart failure and cardiology clinics
1. Patients aged 70 years or older
2. Diagnosis of chronic heart failure according to the European Society of Cardiology guidelines
3. Evidence of Left Ventricular (LV) systolic dysfunction
4. In the New York Heart Association class II or III
Key exclusion criteria1. Aortic stenosis with peak gradient >30 mmHg
2. Sustained Ventricular Tachycardia (VT) or Ventricular Fibrillation (VF) outside of the context of an acute myocardial infarction
3. Unstable angina
4. Unable to walk without human assistance
5. Atrial fibrilation with a ventricular rate of >100/min
6. Currently enrolled in another trial
Date of first enrolment06/08/2007
Date of final enrolment05/08/2010

Locations

Countries of recruitment

  • Scotland
  • United Kingdom

Study participating centre

University of Dundee
Dundee
DD1 9SY
United Kingdom

Sponsor information

University of Dundee (UK)
University/education

Research and Innovation Services
11 Perth Road
Dundee
DD1 4HN
Scotland
United Kingdom

Phone +44 (0)1382 344436
Email research@dundee.ac.uk
ROR logo "ROR" https://ror.org/03h2bxq36

Funders

Funder type

Government

Chief Scientist Office (ref: CZH/4/426) (UK)
Government organisation / Local government
Alternative name(s)
CSO
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planNot provided at time of registration
IPD sharing planThe protocol is available from the authors on request but is not available online. Study data are available for non-commercial, bona-fide academic analyses in collaboration with the authors; decisions on data access will be made between the investigators and the Sponsor (University of Dundee). Participant consent for unrestricted sharing of individual participant data was not obtained. Contact for data sharing: Dr Catrina Forde (c.forde@dundee.ac.uk)

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2012 Yes No
Basic results 18/05/2018 18/05/2018 No No

Additional files

ISRCTN51615566_BasicResults_18May18.pdf
Uploaded 18/05/2018

Editorial Notes

21/05/2018: Ethics approval details updated.
18/05/2018: IPD sharing statement and plain English summary added. The basic results of this trial have been uploaded as an additional file.